Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema
Clinical trial NCT05399550 · WITHDRAWN
Trial details
- NCT number
- NCT05399550
- Sponsor
- Hoffmann-La Roche
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-22
- Primary completion
- 2022-11-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.